United States
Germany
Japan
United Kingdom
China
EBLN2 mouse monoclonal antibody,clone OTI1A2
| Applications | WB |
| Reactivities | Human |
Antibodies
EBLN2 mouse monoclonal antibody,clone OTI2D5
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody, clone OTI1B5 (formerly 1B5)
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody, clone OTI3E1 (formerly 3E1)
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody, clone OTI2H1 (formerly 2H1)
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody,clone OTI1C5
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody, clone OTI2H1 (formerly 2H1), Biotinylated
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody, clone OTI3E1 (formerly 3E1), Biotinylated
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody, clone OTI1B5 (formerly 1B5), Biotinylated
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody,clone OTI2D5, Biotinylated
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody,clone OTI1C5, Biotinylated
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody,clone OTI1A2, Biotinylated
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody,clone OTI1A2, HRP conjugated
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody,clone OTI1C5, HRP conjugated
| Applications | WB |
| Reactivities | Human |
EBLN2 mouse monoclonal antibody, clone OTI3E1 (formerly 3E1), HRP conjugated
| Applications | WB |
| Reactivities | Human |
